BIBDX
Price
$13.09
Change
+$0.07 (+0.54%)
Updated
Jun 2 closing price
Net Assets
895.99M
IGHSX
Price
$12.43
Change
-$0.02 (-0.16%)
Updated
Jun 2 closing price
Net Assets
348.37M
Interact to see
Advertisement

BIBDX vs IGHSX

Header iconBIBDX vs IGHSX Comparison
Open Charts BIBDX vs IGHSXBanner chart's image
BIBDX vs IGHSX Comparison Chart in %
View a ticker or compare two or three
VS
BIBDX vs. IGHSX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIBDX is a Hold and IGHSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIBDX has more cash in the bank: 896M vs. IGHSX (348M). IGHSX pays higher dividends than BIBDX: IGHSX (1.66) vs BIBDX (1.29). BIBDX was incepted earlier than IGHSX: BIBDX (18 years) vs IGHSX (18 years). IGHSX (0.95) is less costly to investors than BIBDX (0.80). IGHSX is a more actively managed with annual turnover of: 67.00 vs. BIBDX (44.00). IGHSX has a lower initial minimum investment than BIBDX: IGHSX (0) vs BIBDX (2000000). BIBDX annual gain was more profitable for investors over the last year : 4.72 vs. IGHSX (3.62). IGHSX return over 5 years is better than : 18.76 vs. BIBDX (-1.02).
BIBDXIGHSXBIBDX / IGHSX
Total Expense Ratio0.800.8594%
Annual Report Gross Expense Ratio0.800.9584%
Fund Existence18 years18 years-
Gain YTD10.4383.456302%
Front LoadN/AN/A-
Min. Initial Investment20000000-
Min. Initial Investment IRAN/AN/A-
Net Assets896M348M257%
Annual Yield % from dividends1.291.6678%
Returns for 1 year4.723.62130%
Returns for 3 years23.6627.5686%
Returns for 5 years-1.0218.76-5%
Returns for 10 years32.0079.6340%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAC5.750.24
+4.36%
Lithium Americas Corp
WTBA23.970.38
+1.61%
West Bancorporation
LAFAU10.19N/A
N/A
Lafayette Acquisition Corp
WFCF11.92-0.12
-1.00%
Where Food Comes From
ARWR70.86-4.34
-5.77%
Arrowhead Pharmaceuticals